SCHEDULE 13G: Alyeska Investment Group Discloses 5.48% Stake in Modular Medical, Inc.
Beneficial Ownership Report
Alyeska Investment Group, L.P., along with Alyeska Fund GP, LLC and Anand Parekh, has disclosed a beneficial ownership of 5.48% in Modular Medical, Inc.'s common stock.
Summary
- Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have jointly filed a Schedule 13G, indicating beneficial ownership in Modular Medical, Inc.
- The reporting persons collectively beneficially own 2,229,165 shares of Modular Medical, Inc. common stock.
- This ownership represents 5.48% of the issuer's outstanding common stock.
- The stake includes 1,708,332 shares of common stock and warrants to purchase an additional 520,833 shares.
- The percentage calculation is based on an assumed 40,665,220 outstanding shares of common stock, as reported in Modular Medical, Inc.'s 10-Q filed on February 13, 2025.
- The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that inherently indicates positive or negative sentiment regarding the company's performance or prospects.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
NA
Industry Context
This filing is a standard disclosure of a significant passive investment by an institutional investor in a publicly traded company. It does not provide specific insights into broader industry trends or competitive landscape beyond the fact of the investment itself.
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional investor taking a passive stake can be viewed positively as a vote of confidence or increased liquidity, though the filing explicitly states no intent to influence control.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 02/13/2025 | Date Modular Medical, Inc. filed its 10-Q with the SEC, providing the basis for outstanding shares calculation. |
| 03/31/2025 | Date of event which required the filing of this statement. |
| 05/15/2025 | Date the Schedule 13G was signed and filed. |
Keywords
Modular Medical Inc., Alyeska Investment Group, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.